CCL22-producing CD8α- myeloid dendritic cells mediate regulatory T cell recruitment in response to G-CSF treatment

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2266-2272

  Layseca Espinosa, Esther ^a,b,c   Korniotis, Sarantis ^a,b   Montandon, Ruddy ^a,b   Gras, Christophe ^a,b   Bouillié, Marie ^a,b   Gonzalez Amaro, Roberto ^c   Dy, Michel ^a,b   Zavala, Flora ^a,b  

^a CNRS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8ALPHA ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 2 RECEPTOR ALPHA; MACROPHAGE DERIVED CHEMOKINE; PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT CYTOKINE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTECTION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SPLEEN; TISSUE SPECIFICITY;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD8; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED NOD; MYELOID CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

EID: 84883354718     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202307     Document Type: Article

References (24)

1. Rutella, S., F. Zavala, S. Danese, H. Kared, and G. Leone. 2005. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J. Immunol. 175: 7085-7091.
2. Zavala, F., S. Abad, S. Ezine, V. Taupin, A. Masson, and J. F. Bach. 2002. G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J. Immunol. 168: 2011-2019.
3. Zavala, F., A. Masson, K. Hadaya, S. Ezine, E. Schneider, O. Babin, and J. F. Bach. 1999. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice. J. Immunol. 163: 5125-5132.
4. Hadaya, K., H. Kared, A. Masson, L. Chatenoud, and F. Zavala. 2005. G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse. J. Autoimmun. 24: 125-134.
5. Kared, H., A. Masson, H. Adle-Biassette, J.-F. Bach, L. Chatenoud, and F. Zavala. 2005. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes 54: 78-84.
6. van Belle, T. L., K. T. Coppieters, and M. G. von Herrath. 2011. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol. Rev. 91: 79-118.
7. Parker, M. J., S. Xue, J. J. Alexander, C. H. Wasserfall, M. L. Campbell-Thompson, M. Battaglia, S. Gregori, C. E. Mathews, S. Song, M. Troutt, et al. 2009. Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice. Diabetes 58: 2277-2284.
8. Rossetti, M., S. Gregori, and M. G. Roncarolo. 2010. Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naive T cells. Eur. J. Immunol. 40: 3097-3106.
9. Scholz, M., M. Ackermann, F. Emmrich, M. Loeffler, and M. Kamprad. 2009. Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model. Biologics 3: 27-37.
10. Swiecki, M., and M. Colonna. 2010. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol. Rev. 234: 142-162.
11. Matta, B. M., A. Castellaneta, and A. W. Thomson. 2010. Tolerogenic plasmacytoid DC. Eur. J. Immunol. 40: 2667-2676.
12. Shortman, K., and W. R. Heath. 2010. The CD8+ dendritic cell subset. Immunol. Rev. 234: 18-31.
13. Bhattacharya, P., A. Gopisetty, B. B. Ganesh, J. R. Sheng, and B. S. Prabhakar. 2011. GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms. J. Leukoc. Biol. 89: 235-249.
14. Iellem, A., M. Mariani, R. Lang, H. Recalde, P. Panina-Bordignon, F. Sinigaglia, and D. D'Ambrosio. 2001. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 194: 847-853.
15. Pere, H., Y. Montier, J. Bayry, F. Quintin-Colonna, N. Merillon, E. Dransart, C. Badoual, A. Gey, P. Ravel, E. Marcheteau, et al. 2011. A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. Blood 118: 4853-4862.
16. Chen, M., L. Huang, Z. Shabier, and J. Wang. 2007. Regulation of the lifespan in dendritic cell subsets. Mol. Immunol. 44: 2558-2565.
17. Hanabuchi, S., T. Ito, W. R. Park, N. Watanabe, J. L. Shaw, E. Roman, K. Arima, Y. H. Wang, K. S. Voo, W. Cao, and Y. J. Liu. 2010. Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J. Immunol. 184: 2999-3007.
18. Sarkar, S. A., C. E. Lee, F. Victorino, T. T. Nguyen, J. A. Walters, A. Burrack, J. Eberlein, S. K. Hildemann, and D. Homann. 2012. Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes 61: 436-446.
19. Kim, S. H., M. M. Cleary, H. S. Fox, D. Chantry, and N. Sarvetnick. 2002. CCR4-bearing T cells participate in autoimmune diabetes. J. Clin. Invest. 110: 1675-1686.
20. Montane, J., L. Bischoff, G. Soukhatcheva, D. L. Dai, G. Hardenberg, M. K. Levings, P. C. Orban, T. J. Kieffer, R. Tan, and C. B. Verchere. 2011. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. J. Clin. Invest. 121: 3024-3028.
21. Lee, I., L. Wang, A. D. Wells, M. E. Dorf, E. Ozkaynak, and W. W. Hancock. 2005. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201: 1037-1044.
22. Kared, H., B. Leforban, R. Montandon, A. Renand, E. Layseca Espinosa, L. Chatenoud, Y. Rosenstein, E. Schneider, M. Dy, and F. Zavala. 2008. Role of GM-CSF in tolerance induction by mobilized hematopoietic progenitors. Blood 112: 2575-2578.
23. Kared, H., H. Adle-Biassette, E. Foïs, A. Masson, J. F. Bach, L. Chatenoud, E. Schneider, and F. Zavala. 2006. Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling. Immunity 25: 823-834.
24. Bonanno, G., A. Procoli, A. Mariotti, M. Corallo, A. Perillo, S. Danese, R. De Cristofaro, G. Scambia, and S. Rutella. 2010. Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies. J. Transl. Med. 8: 114.